A2553

Dénomination commerciale

non renseigné

06974323011422

B-06974323011422

Numéro de référence/catalogue

A2553

GS1

IVDD — Général

Législation applicable

IVDD [Directive 98/79/CE relative aux dispositifs médicaux de diagnostic in vitro]

Statut

Sur le marché

Quantité

1

Description complémentaire du produit

This kit is designed for the confirmation test of Middle East Respiratory Syndrome (MERS) virus nucleic acid extracted from clinical specimens (or virus isolates). The experimental results only provide reference for basic study, and cannot be used as the basis for clinical diagnosis. The Middle East Respiratory Syndrome (MERS) virus was first discovered in Saudi Arabia in September 2012. It is well known because it belongs to the same coronavirus specie of SARS. It is a positive-sense single-stranded RNA virus of the Betacoronavirus of the Coronaviridae of Nidovirales. The most common clinical manifestations of Middle East respiratory syndrome include fever, fever with chills, cough, shortness of breath, and muscle aches; while diarrhea, nausea and vomiting, abdominal pain and other gastrointestinal manifestations are also common.

URL des informations complémentaires

Aucune URL d'informations complémentaires renseignée par le fabricant.

Dimensions cliniques

Aucune dimension clinique enregistrée pour ce dispositif.

Nomenclature européenne des dispositifs médicaux — la classification produit UE attribuée à ce dispositif.

• W0105070503RESPIRATORY TRACT INFECTIONS - MULTIPLEX NA REAGENTS